Andrew Hollman Meyer - Chief Business Officer at Janux Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
JANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Andrew Hollman Meyer - trading volume in the past year for Janux Therapeutics, Inc.

Holdings reported by Andrew Hollman Meyer for Janux Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 85K $2.55M $30.00 Nov 14, 2025 Direct
Stock Option (right to buy) 118K Nov 14, 2025 Direct Common Stock

Transactions reported by Andrew Hollman Meyer for Janux Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.